US Patent Issued to Rapamycin Holdings on March 4 for "Oral rapamycin nanoparticle preparations and use" (Texas Inventors)

ALEXANDRIA, Va., March 5 -- United States Patent no. 12,239,737, issued on March 4, was assigned to Rapamycin Holdings Inc. (San Antonio).

"Oral rapamycin nanoparticle preparations and use" was invented by Dana Vaughn (Seguin, Texas) and Neal K. Vail (Castle Hills, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "Oral preparations of microcapsules and nanoparticles including an inhibitor of the mammalian target of rapamycin. The preparations are intended to assist with the treatment and prevention of cancer, neurocognitive dysfunction, genetically predisposed disorders, and age-related disorders. The embodiments discussed address the present need for alternative preparations or manufacturing processes th...